Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nigel Brayshaw"'
Autor:
Rosalind Walley, Nigel Brayshaw
Publikováno v:
Pharmaceutical statisticsREFERENCES. 21(4)
In industry, successful innovation involves not only developing new statistical methodology, but also ensuring that this methodology is implemented successfully. This includes enabling applied statisticians to understand the method, its benefits and
Autor:
Javaria Mona Khalid, W J Sandborn, Parnia Geransar, Nigel Brayshaw, J.-F. Colombel, Brian G. Feagan, Sharon O'Byrne, David T. Rubin
Publikováno v:
Journal of Crohn's and Colitis. 11:S36-S38
Publikováno v:
Journal of Crohn's and Colitis. 12:S460-S461
Publikováno v:
Gastroenterology. 154:S-370
Publikováno v:
The Journal of Clinical Pharmacology. 46:235-243
This study investigated the relationship between plasma voriconazole concentrations (pVC) and risk of visual adverse events (VAEs) or liver function test (LFT) abnormalities using longitudinal logistic regression. Seven-day mean pVC were calculated f
Autor:
Javaria Mona Khalid, William J. Sandborn, David T. Rubin, Parnia Geransar, Sharon O'Byrne, Brian G. Feagan, Jean-Frederic Colombel, Nigel Brayshaw
Publikováno v:
Gastroenterology. 152:S597
Introduction Reported rates of extraintestinal manifestations (EIMs) in patients (pts) with Crohn’s disease (CD) are 37%–55%. 1,2 This post hoc exploratory analysis investigated the effect of vedolizumab (VDZ) treatment on existing and new EIMs i
Autor:
Nigel Brayshaw
Publikováno v:
Journal of the Royal Statistical Society: Series D (The Statistician). 52:243-244
Autor:
Ghazwan Butrous, Nigel Brayshaw, Ranji Thomas, K. Kamalvand, Jane Fisher, Richard Heppell, Sarah Cluck, Claire Gilbert
Publikováno v:
BMC Pharmacology. 7(Suppl 1):P59
Introduction Sildenafil inhibits phosphodiesterases type 5, an enzyme that metabolizes cGMP. It is approved for the treatment of erectile dysfunction and pulmonary arterial hypertension. Early clinical studies showed a beneficial effect in endothelia